Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells
Haneen Amawi(Yarmouk University), Amit K. Tiwari(University of Arkansas for Medical Sciences)
Cited by 19
Related Papers
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65
A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells
|Cancers|2021|20